1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

13 Nov 2024
Admin
News Article

STEERLife & Callidus Research Laboratories Forge Strategic Partnership

STEERLife & Callidus Research Laboratories forge strategic partnership to accelerate innovative drug development

Overview

STEERLife, a pioneer in pharmaceutical development technologies, and Callidus Research Laboratories, a formulation development services company with a wealth of experience in comprehensive pharmaceutical drug development, have forged a strategic partnership to accelerate drug development for global markets.

The Collaboration

The collaboration combines STEERLife's advanced Hot Melt Extrusion (HME) and Continuous Processing Technologies with Callidus' Pharmaceutical Drug Development Expertise, addressing the global demand for innovative drug formulations and development.

Companies Post Collab

The two companies will provide worldwide clients with advanced drug development services utilising Hot Melt Extrusion technology.
This partnership enables both organisations to integrate their specialised knowledge and skills, yielding innovative solutions and enhanced product offerings.
Additionally, the collaboration facilitates network, contact, and market reach sharing, allowing both companies to enter new regions and customer segments.
Jointly, they will meet the global demand for next-generation pharmaceutical formulations, serving generic and brand companies.

Partnership Impact on Drug Development

This partnership also enables end-to-end drug development for highly potent APIs.
Beyond their complementary capabilities, the organisations’ collaboration is fuelled by their shared commitment to pushing the boundaries of innovation to further futuristic product development for global markets.

Words from the CEO: STEERLife

"Our partnership with Callidus Research Laboratories represents a significant leap forward in pharmaceutical innovation. This collaboration empowers clients with cutting-edge technologies, extensive product development expertise, and seamless scale-up capabilities," said Indu Bhushan, CEO, STEERLife.

From Callidus Research Laboratories

"Partnering with STEERLife enhances our capabilities, allowing us to provide comprehensive, innovative solutions to pharmaceutical companies worldwide. This collaboration exemplifies our dedication to pushing boundaries, fostering growth, and improving patient outcomes through transformative pharmaceutical solutions,” said Vardhaman Bafna, co-founder & director, Callidus Research Laboratories.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!